
|Articles|July 1, 2001
Should MVAC be standard of care for bladder Ca?
San Francisco-Results from a 14-year Southwest Oncology Group trial show for the first time that neoadjuvant chemotherapy plus cystectomy offers improved survival over cystectomy alone in the treatment of patients with locally advanced bladder cancer. This finding challenges the results of seven previous clinical studies.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Sildenafil cream for female sexual arousal disorder available to prescribe in select states
2
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
3
FDA approves ProVee System for benign prostatic hyperplasia
4
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
5















